Eton Pharmaceuticals (NASDAQ:ETON) is preparing to release its quarterly earnings on Tuesday, 2025-05-13. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Eton Pharmaceuticals to report an earnings per share (EPS) of $0.03.
The announcement from Eton Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
The company’s EPS missed by $0.00 in the last quarter, leading to a 1.36% increase in the share price on the following day.
Here’s a look at Eton Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.02 | -0.01 | -0.07 | -0.07 |
| EPS Actual | -0.02 | 0.02 | -0.12 | -0.03 |
| Price Change % | 1.0% | 16.0% | 3.0% | -0.0% |
Performance of Eton Pharmaceuticals Shares
Shares of Eton Pharmaceuticals were trading at $16.79 as of May 09. Over the last 52-week period, shares are up 360.74%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts’ Perspectives on Eton Pharmaceuticals
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Eton Pharmaceuticals.
The consensus rating for Eton Pharmaceuticals is Buy, derived from 3 analyst ratings. An average one-year price target of $27.67 implies a potential 64.8% upside.